iCarbonX is a Chinese health technology company founded on October 27, 2015, by genomicist Jun Wang, former CEO of the Beijing Genomics Institute (BGI). The company aims to digitize human life by integrating genomics with other health determinants, including metabolites, bacteria, and lifestyle choices, to create a comprehensive, data-driven model of individual health. Its name symbolizes the use of the internet and artificial intelligence to improve life, with carbon as a central element of biology, and the "i" and "X" representing the combination of internet and AI to create something new.
History and Funding
Founded in Shenzhen, China, iCarbonX quickly attracted significant investment. By early 2017, the company had raised over $600 million, including a $200 million investment from Tencent Holdings (owner of WeChat) and Zhongyuan Union Cell & Gene Engineering Corp. This funding made iCarbonX one of only three Chinese healthcare startups to achieve a valuation exceeding $1 billion, a status often referred to as a "unicorn." The company maintained a lean workforce of about 100 employees.
Digital Life Alliance and Acquisitions
On September 10, 2016, iCarbonX acquired Imagu Vision Technologies, an Israeli artificial intelligence and image processing company, to establish an iCarbonX-Israel R&D center. On January 5, 2017, iCarbonX announced the Digital Life Alliance, a partnership with seven other companies: SomaLogic, HealthTell, PatientsLikeMe, AOBiome, GALT, Imagu, and Robustnique. This alliance was designed to pool expertise across genomics, proteomics, metabolomics, and patient networks to advance the company's digital life vision.
Products and Partnerships
On January 5, 2017, iCarbonX released Meum, a digital health management platform. The same day, it announced a partnership with PatientsLikeMe, an online network for patients with chronic conditions, investing $100 million in the company. The collaboration aimed to combine genetic sequencing projects with patient-reported data to improve health outcomes.
Technology and Approach
iCarbonX leverages Artificial intelligence and Machine learning to analyze multi-omic data, including genomics, metabolomics, and microbiome information, alongside lifestyle and environmental factors. The company's approach aligns with the broader trend of Generative AI and Deep learning in healthcare, though its focus is on personalized health management rather than general-purpose AI. By integrating data from diverse sources, iCarbonX seeks to create a "digitalized life" that can predict health risks and guide interventions.
References
- Source facts from Wikipedia (CC BY-SA).